Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_3
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (66.7%)
N/A1 (33.3%)

Trials by Status

completed250%
unknown125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism

NCT04409431
completed

Effects of Adrenal Artery Ablation and Adrenalectomy in Patients With Primary Aldosteronism

NCT04269928
completedphase_3

Adrenal Artery Ablation Treats Primary Aldosteronism

NCT03398785
unknownphase_3

Adrenal Artery Ablation for Primary Aldosteronism

NCT03653845

Clinical Trials (4)

Showing 4 of 4 trials
NCT04409431Not Applicable

Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism

Recruiting
NCT04269928

Effects of Adrenal Artery Ablation and Adrenalectomy in Patients With Primary Aldosteronism

Completed
NCT03398785Phase 3

Adrenal Artery Ablation Treats Primary Aldosteronism

Completed
NCT03653845Phase 3

Adrenal Artery Ablation for Primary Aldosteronism

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4